CINECA IRIS Institutional Research Information System

GUERRINI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.023
AS - Asia 2.554
EU - Europa 2.499
SA - Sud America 409
AF - Africa 143
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.651
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.854
IT - Italia 820
CN - Cina 746
SG - Singapore 738
SE - Svezia 505
HK - Hong Kong 396
BR - Brasile 347
GB - Regno Unito 285
DE - Germania 273
VN - Vietnam 259
BG - Bulgaria 175
CA - Canada 121
TR - Turchia 115
FR - Francia 100
FI - Finlandia 90
RU - Federazione Russa 80
JP - Giappone 64
IN - India 57
CI - Costa d'Avorio 54
UA - Ucraina 36
BE - Belgio 33
SN - Senegal 28
KR - Corea 26
BD - Bangladesh 25
MX - Messico 24
PH - Filippine 23
AR - Argentina 18
AU - Australia 18
NL - Olanda 17
ES - Italia 16
ZA - Sudafrica 15
PK - Pakistan 14
SA - Arabia Saudita 14
UZ - Uzbekistan 14
PL - Polonia 13
CH - Svizzera 12
IQ - Iraq 11
EC - Ecuador 10
NG - Nigeria 10
MA - Marocco 9
KE - Kenya 8
MY - Malesia 8
TN - Tunisia 8
AT - Austria 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
PY - Paraguay 6
CO - Colombia 5
EG - Egitto 5
ID - Indonesia 5
IE - Irlanda 5
JO - Giordania 5
LT - Lituania 5
UY - Uruguay 5
CL - Cile 4
GR - Grecia 4
HN - Honduras 4
IR - Iran 4
KZ - Kazakistan 4
RO - Romania 4
BO - Bolivia 3
BS - Bahamas 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EU - Europa 3
PE - Perù 3
PS - Palestinian Territory 3
AZ - Azerbaigian 2
BM - Bermuda 2
BT - Bhutan 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
NI - Nicaragua 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SR - Suriname 1
Totale 10.649
Salva come PNG Salva come JPEG
Città #
Ashburn 529
Hong Kong 391
Serra 389
Singapore 386
Woodbridge 365
Fairfield 359
Santa Clara 327
San Jose 284
Ann Arbor 271
Houston 270
Chandler 261
Dallas 232
Beijing 199
Seattle 194
Sofia 170
Shanghai 152
Wilmington 146
Cambridge 125
New York 122
Boardman 111
Milan 101
Los Angeles 87
Princeton 86
London 81
Ottawa 78
Florence 68
Munich 67
Izmir 60
Medford 60
Lawrence 59
Abidjan 54
Lauterbourg 52
Tokyo 50
Ho Chi Minh City 49
Council Bluffs 44
Jacksonville 42
Des Moines 41
Dearborn 35
Hanoi 35
Nanjing 35
Istanbul 32
San Diego 30
Dakar 28
Helsinki 28
Dong Ket 27
Lancaster 24
São Paulo 24
Brussels 23
Frankfurt am Main 23
Pisa 23
Buffalo 22
Rome 21
Bremen 20
Redwood City 20
Nanchang 19
Redondo Beach 19
Hefei 18
Rio de Janeiro 18
Turku 16
Changsha 14
Shenyang 14
Tashkent 13
Alessandria 12
Orem 12
Toronto 12
Düsseldorf 11
Fuzhou 11
Manila 11
Columbus 10
Nuremberg 10
Phoenix 10
Porto Alegre 10
The Dalles 10
Brooklyn 9
Duncan 9
Falkenstein 9
Lagos 9
Montreal 9
Warsaw 9
Amsterdam 8
Bern 8
Chicago 8
Haiphong 8
Hebei 8
Jüchen 8
Melbourne 8
Nairobi 8
Ankara 7
Boston 7
Boulder 7
Cascina 7
Chengdu 7
Da Nang 7
Denver 7
East Lansing 7
Hangzhou 7
Jiaxing 7
Kunming 7
Mumbai 7
Norwalk 7
Totale 7.271
Salva come PNG Salva come JPEG
Nome #
The perception of stress in cat owners 330
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia 250
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma 238
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia 217
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 214
Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment 213
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen 202
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia 202
Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib 202
Combined unfavourable polymorphisms ofhOCT1 and ABCG2 are responsible for delayed complete cytogenetic response during imatinib treatment. 199
The combination of rituximab and bendamustine as first-line treatment is highly effective in the eradicating minimal residual disease in follicular lymphoma: An Italian retrospective study 198
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study. 197
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia 194
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 192
Transmembrane Transporters hOCT1 and SLCO1B3 Polymorphisms Could Have a Role in Patients Affected By Chronic Myeloid Leukemia Treated with Nilotinib 188
TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME 185
MDS: An Integrated Workup for a Correct Diagnosis 184
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 184
A PRACTICAL APPROACH TO THERAPEUTIC DRUG MONITORING OF IMATINIB IN PATIENTS AFFECTED BY CHRONIC MYELOID ELEUKEMIA. THE TIKLET PROTOCOL. 183
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup 181
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation 181
Droplet digital PCR represents a new sensitive method for detecting B-RAFV600E mutation at diagnosis and during the follow-up of patients affected by hairy cell leukemia 178
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 trial 178
Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis 175
Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. 174
LOW RPS14 EXPRESSION IS FREQUENTLY FOUND IN NON-5Q-MYELODYSPLASTIC SYNDROMES 169
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 167
Comparison of Real-Time PCR and Droplet Digital PCR for the Determination of JAK2V617F Mutation in Ph'-Negative Myeloproliferative Neoplasms 167
Increased values of the circulating PDGFβ sustains the "withdrawal syndrome" after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemia 166
PLATELET-DERIVED GROWTH FACTOR BETA RECEPTOR (PDGFRB) GENE IS REARRANGED IN A SIGNIFICANT PERCENTAGE OF MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE 166
Molecular detection of GNNK- and GNNK+ c-kit isoforms: a new tool for risk stratification in adult acute myeloid leukaemia 163
Combined FAMD and ANOVA investigation leads to significant association between the hOCT1/ABCB1 diplotype and both efficacy and tolerability in patients affected by chronic myeloid leukemia 163
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice 163
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia 161
ZINC ORAL SUPPLEMENTATION INDUCES A SIGNIFICANT RISE OF TRECS AND T CD4+ NAΪVE AND PREVENTS THE INCREASE OF TTV VIRAL LOAD AFTER STEM CELL TRANSPLANTATION: THE ZENITH STUDY 160
A Novel Digital PCR Assay for MYD88 L265P Mutation Detection in Waldenstrom Macroglobulinemia: Minimal Residual Disease Monitoring and Characterization on Circulating Free DNA 159
Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients 158
Altered Expression of Jak-Stat Pathway as Possible Predictive Marker in Patients Affected by Chronic Myeloid Leukemia Receiving Tyrosin Kinase Inhibitors (TKIS) 158
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients 156
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2 153
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab 149
PRDI-BF1 and PRDI-BF1P isoform expressions correlate with disease status in multiple myeloma patients 149
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation 149
TYROSINE KINASE INHIBITORS SIGNIFICANTLY CHANGE THE EXPRESSION OF POLYCOMB GENES IN CHRONIC MYELOID LEUKEMIA 149
WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes 147
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EOSINOPHILOIA IN EGPA FROM HES 146
Conventional Cytogenetics, ACGH, and PCR as Integrated Workup for a Correct Diagnosis of MDS 143
R-IPSS, RPS14 AND WT1 LEVELS ARE THE BEST PROGNOSTIC FACTORS FOR PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE TREATMENT. 142
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation 140
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line 138
Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients 135
Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H). 133
Platelet-derived growth factor beta receptor (PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype 132
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma 130
The clinical relevance of the expression of several multidrug-resistant-related genes in patients with primary acute myeloid leukemia 128
Myelodysplastic Syndromes: A Multidisciplinary Integrated Diagnostic Work-up for Patients' Risk Stratification 126
THE C.480C>G POLYMORPHISM OF HOCT1 TRANSPORTER INFLUENCES IMATINIB CLEARANCE IN PATIENTS AFFECTED BY CHRONIC MYELOID LEUKEMIA 125
ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression study. 121
Digital droplet PCR is a specific and sensitive tool for detecting IDH2 mutations in acute myeloid leukemia patients 119
FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemia 116
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia 116
quantitative molecular detection of IgH rearrangement in multiple myeloma: comparison of two innovative techniques 111
Real-Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2(V617F) mutation in Philadelphia-negative chronic myeloproliferative neoplasms 110
A new digital droplet PCR method for looking at epigenetics in diffuse large B‐cell lymphomas: The role of BMI1, EZH2, and USP22 genes 94
molecular evaluation of minimal residual disease in multiple myeloma 92
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool 89
Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real‐Life Italian Multicenter Harmonization Experience 17
Totale 10.814
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022859 30 42 13 64 144 117 30 32 70 29 70 218
2022/20231.062 159 210 68 72 86 116 8 85 168 6 79 5
2023/2024691 59 54 97 40 77 120 37 19 9 44 22 113
2024/20252.284 11 75 15 131 258 243 198 134 208 279 217 515
2025/20262.374 170 255 290 224 265 208 327 124 142 243 84 42
2026/202720 20 0 0 0 0 0 0 0 0 0 0 0
Totale 10.814